Eli Lilly (NYSE: LLY) stock defied today's market downturn, rising 2.6% through 11:15 a.m. ET on the back of two positive press releases. In one, Lilly announced plans to acquire the farnesoid X ...
Hims & Hers stock tumbled after the company confirmed it would stop selling some compounded weight-loss drugs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback